Celiac disease: Guideline update overview

Area of Science:

• Gastroenterology
• Autoimmune Disorders
• Clinical Guidelines

Background:

• Celiac disease is an autoimmune disorder triggered by gluten ingestion.
• It leads to malabsorption and presents with diverse gastrointestinal and non-gastrointestinal symptoms.
• Early diagnosis and management are crucial for patient outcomes.

Purpose of the Study:

• To provide an overview of the updated 2023 clinical guideline for celiac disease.
• To enhance awareness among healthcare providers, particularly Nurse Practitioners (NPs), regarding diagnosis and management.
• To guide NPs in identifying and referring patients for appropriate gastroenterology evaluation.

Main Methods:

• Review of the American College of Gastroenterology's 2023 clinical guideline.
• Synthesis of key recommendations for celiac disease diagnosis.
• Summary of current management strategies for celiac disease.

Main Results:

• The guideline emphasizes updated diagnostic criteria and management approaches.
• Recognition of a broad spectrum of clinical presentations is highlighted.
• The importance of timely referral to gastroenterology specialists is reinforced.

Conclusions:

• Adherence to the 2023 guideline facilitates accurate celiac disease diagnosis.
• Increased NP awareness improves patient care through early detection and referral.
• Effective management hinges on understanding the multifaceted nature of celiac disease.